To review and summarize the current literature of the implications of obesity on nononcological urological surgery. We conducted a comprehensive search of the current literature with emphasis on the published literature in the last 18 months.
INTRODUCTION
The prevalence of obesity is increasing worldwide [1] . It is estimated that more than one half of the world's population will be at least overweight by 2030. Moreover, obesity is serious health problem as it is a well recognized risk factor for multiple chronic diseases [2] .
BMI is used to assess and classify obesity. According to the WHO, overweight is defined as a BMI at least 25 and obesity is defined as a BMI at least 30 [3] . Obesity is classified into class I (BMI of 30-34. [4] . Furthermore, waist circumference is a simple tool and surrogate measure to assess central obesity [5] . Central obesity, together with dyslipidemia, hypertension, insulin resistance with subsequent impaired glucose metabolism, is a core manifestation of the metabolic syndrome (MetS) [5] [6] [7] . There are different waist circumference cut-offs to identify central obesity. The threshold for waist circumference in Europeans was recommended to be 94 cm for men and 80 cm for women, whereas the American Heart Association/National Heart, Lung, and Blood Institute recommended a cut-off of 102 and 88 cm, respectively [5] .
Obesity has been linked to an increased risk of perioperative complications in surgical patients [4] .
Many factors may explain this association, such as the higher prevalence of diabetes mellitus, hyperlipidemia, hypertension, and coronary heart disease [2] . In addition, the cardiorespiratory changes, thromboembolic tendency, and technical challenges encountered at the time of surgery play a significant role in perioperative outcomes. Nevertheless, solid evidence regarding the association between obesity and surgical morbidity is an unmet need [8, 9] . In fact, after open elective general surgery, obesity was not identified as a risk factor for postoperative complications except for an increased risk of wound infections [8] . Other studies identified obesity as a significant predictor of more surgical blood loss and a longer operation time [9, 10 && ]. We sought to review and summarize the current literature about the impact of obesity on postoperative outcomes in nononcological urological surgeries with an emphasis on perioperative complications.
EVIDENCE ACQUISITION
An English language literature search using the PubMed-Medline database covered the literature from October 2015 to April 2017. The search strategy included these broad terms in isolation or in combination 'obesity', 'BMI', 'waist circumference', 'superobese', 'MetS', 'postoperative complication', 'morbidity', 'benign prostatic enlargement', 'open prostatectomy', ' simple nephrectomy', 'nephrolithiasis', 'percutaneous nephrolithotomy (PNL)', 'incontinence surgery', 'sling procedure', 'ureteroscopy', 'renal transplant', 'urological surgery'.
Relevant articles related to outcomes in obese patients who underwent nononcological urological surgery were selected. We identified original articles and reviews. All studies were obtained as full text articles. Additional relevant articles were selected from authors' bibliographies. Case reports, editorial, and congress abstracts were excluded. Study eligibility was determined by two authors (M.A. and A.M.).
EVIDENCE SYNTHESIS

Surgery for benign prostate enlargement in obese patients
Results from several epidemiological studies and meta-analyses showed an association between MetS and obesity with benign prostate enlargement (BPE), lower urinary tract symptoms, and progression of BPE [11] [12] [13] . The impact of MetS and its components on the outcome of transurethral resection of the prostate (TURP) has been evaluated [14, 15 && ]. MetS was found to have a negative impact after TURP in terms of postoperative international prostate symptom score (IPSS), maximum urine flow rate, and quality of life (QoL). Furthermore, abdominal obesity -as a component of MetS -retained the independent negative association with QoL [14] . The functional outcomes after surgical treatment of BPE have also been evaluated in a larger prospective study that included 378 patients [15 && ]. Patients with MetS had worse postoperative symptoms (measured by total and storage IPSS) in comparison to patients without MetS. Moreover, patients with a waist circumference of at least 102 cm had a threefold higher risk of an incomplete recovery of symptoms and a five-fold higher risk of having persistent symptoms after TURP or open prostatectomy. A retrospective study of 125 patients that evaluated the effectiveness of high-power greenlight laser in comparison to TURP reported different results [16] . In subgroup analysis after adjustment for baseline IPSS, patients with BMI at least 24 who underwent greenlight laser had better adjusted IPSS and QoL than patients who underwent TURP. Upcoming minimal invasive techniques might further minimize the difference in the outcome for patients with an increased BMI [17] .
Surgery for urinary incontinence in obese patients
Overweight and obesity status are important risk factors for urgency, stress, and mixed urinary
KEY POINTS
Obese patients undergoing surgical intervention for BPE are at higher risk of persistent symptoms after open and endoscopic surgery.
Evidence points toward the fact that obese women undergoing surgery for urinary incontinence are likely to have comparable outcomes in term of success and complications.
PNL still has a major role in obese patients with high success rates. The body of literature reports comparable complication rates among all BMI groups even in superobese patients.
Retrograde intrarenal surgery achieves similar success rates among obese and nonobese with low complication rates. On the other hand, ureteroscopy seems to result in lower stone free and higher retreatment rates in obese patients.
Obese patients have higher risk of postoperative complications and DGFs. Data regarding graft survival are not consistent and patient survival seems to be unaffected.
incontinence [18] [19] [20] . Indeed, BMI is an independent risk factor for the incidence of urinary incontinence [21] . Midurethral slings (MUS) such as transobturator tape (TOT) and tension-free vaginal tape (TVT) have gained large popularity and led to dramatic increase in antiincontinence procedures in women [22] . In fact, MUS procedures are the standard treatment for female stress urinary incontinence [23 & ]. Single incision mid-urethral slings represents the third generation of MUS procedures in which a minisling is inserted through a single vaginal incision and fixed to pelvic wall tissues without blind tape passage [24] . Several investigators addressed the concern of lower cure rates and higher complication rates in obese women with conflicting results [23 & ,24-28,29 & ]. In a retrospective comparative study, Pereira et al. [29 & ] evaluated the effectiveness and safety of transobturator MUS Tension-free Vaginal TapeObturator (TVT-O) in 281 women with pure stress or mixed urinary incontinence. During a follow-up period of 48 months, the objective cure rates were at least 95% at each follow-up visit (6, 12, 24 , and 48 months) with no statistically significant differences between obese women and nonobese counterparts. This was also true in term of QoL. Moreover, complications rates were low with no significant differences between groups. Similarly, a recent report demonstrated similar success rates in obese women and nonobese women who underwent retropubic MUS [30,31 & ]. In contrast, a secondary analysis [23 & ] of a randomized trial [32] that enrolled 182 women treated with MUS surgery showed that obese women had a statistically significantly lower subjective and objective cure rates 1 year after surgery. However, no statistical differences were observed in terms of complications such as bladder perforation or blood loss. Interestingly, obese women had earlier return to normal voiding after surgery. Similar to previous reports, obesity was not associated with higher complication rates. The long-term outcome of retropubic MUS in women with pure stress urinary incontinence was evaluated by Serati et al. [33 && ] at 13-year followup. Obesity was the only independent predictor of subjective, objective, and urodynamic recurrence of stress urinary incontinence. In 2015, Weltz et al. [34] reported in a systematic review that included 13 articles comparable subjective and objective cure rates in obese and nonobese women treated with MUS for urinary incontinence. Complication rates were also comparable except for a higher rate of bladder preformation in nonobese women.
Meschia et al. [24] showed that women undergoing single incision midurethral slings procedures in all BMI categories experienced an improvement in their condition with an overall objective sure rate of 88%. However, obesity was significantly associated with a lower objective cure rate 1 year after surgery. Complication rates were relatively low with no statistical differences between obese, overweight, and normal patients.
The association between obesity and mixed urinary incontinence cannot be explained by mechanical factors caused by increased weight alone [35] . Treatment in this group starts with lifestyle modification including weight loss. After failure of conservative measure and medical treatment of the urge and urgency related components, onabotulinum toxin and sacral neuromodulation can be considered. Obesity seems not to influence the success of such approaches. Nevertheless, sacral neuromodulation is more difficult to perform in obese patients [18] , whereas the percutaneous tibial nerve stimulation and the recent started chronicv tibial neuromodulation might be a better option in the group of this patients.
There is consistent association between obesity and different types of pelvic organ prolapse (POP) [36, 37] . Nevertheless, nonsurgical and surgical weight loss are not associated with improvement or reversal of symptoms in women with POP [18, 37] . Instead, weight loss helps to halt the progression of symptoms. A comparison between obese and nonobese patients undergoing robotic sacrocolpopexy for treatment of POP showed no difference regarding anatomical support at 12-month postsurgery. A report that included 195 Asian women who underwent vaginal sacrospinous ligament fixation with anterior mesh repair showed similar objective outcomes in obese and nonobese women [38] . Obesity (defined as BMI !27.5) was associated with less improvement in subjective outcomes. In one study the included 335 patients, mesh exposure after vaginal repair of POP was reported in 8% of patients [39] . Lower BMI was identified as a predictor of mesh exposure.
In men, a common cause of urinary incontinence is stress urinary incontinence that results from sphincter dysfunction after radical prostatectomy. The prevalence of this condition is rising with increased number of performed radical prostatectomy. In general, surgical treatment consists of artificial urinary sphincter (AUS) for persistent moderate to severe cases and male slings for mild to moderate cases [40] . Leruth et al. [41] reported the midterm results of a prospective study evaluating the inside-out transobturator male sling in treating postradical prostatectomy stress urinary incontinence. Obesity was an independent risk factor for sling failure [Hazard Ratio (HR): 2.58, P ¼ 0.042]. In a recent large series evaluating the impact of diabetes and obesity on primary AUS outcomes, subjective outcome as measured by pad/day usage was lower in patients with higher BMI [42 & ]. Increasing BMI was not associated with increased risk of reintervention, mechanical failure, or urethral atrophy. Interestingly, obesity was independently associated with reduced risk of infection and erosion in dosedependent relationship (HR: 0.39, P ¼ 0.02). The author attributed these findings to better nutritional status, tissue availability, and lower mechanical pressure applied directly to the prosthetic device. Wang et al. [43] reported on a long-term analysis of outcome after AUS failure. More than half of the 149 patients underwent subsequent procedure. Obese patients represented about 20% of patients. Obesity was found to be associated with 2.6 higher risk to experience mechanical failure.
Surgery for urolithiasis in obese patients
Obesity plays a major role in increasing the risk of urolithiasis [44] . In addition, overweight and obesity status were found to be associated with larger stone size [45] . Furthermore, obesity is a major obstacle for an efficient shock wave lithotripsy (SWL) because of difficulties in stone localization, increase skin-tostone distance weakening the shock wave signal, and the maximum weight carrying limit of lithotripter table [46 & ]. According to the European Association of Urology guidelines, SWL or flexible ureterorenoscopy (fURS) are the first-line interventions for the treatment of kidney stones less than 2 cm. However, severe obesity that prevents targeting the stone is still a contraindication for SWL [46 & ]. PNL is the gold standard for treatment of staghorn stones and renal stones larger than 2 cm [46 & ]. Applying PNL in obese patients carries a wide range of challenges such as difficulties in identifying anatomical landmarks, proper radiological visualization of stone, well tolerated positioning of the patient in addition to the shortcoming of available instruments.
The effect of BMI on PNL outcomes is still unclear [47] . Several studies reported comparable complications rate and length of hospital stay between obese and nonobese patients. However, operative time was found to be longer in obese patients and data regarding stone-free rates after PNL are still conflicting [46 & , [47] [48] [49] [50] [51] . The reported stone-free rates in obese patients range from 49 to 90% [47] .
A meta-analysis that involved a total of 1686 obese and 286 superobese patients showed that PNL had similar outcomes in terms of complication and stone-free rates among all BMI groups [52 & ]. Superobese patients had a longer operation time compared with nonobese patients. Surprisingly, obese patients had a shorter length of hospital stay in comparison with normal weight counterparts. && ] examined the impact of obesity in patients undergoing PNL. Similar to previous reports, obesity was not associated with greater complication or transfusion rates, even after adjusting for relevant patient and hospital characteristics. Nevertheless, obesity was significantly associated with a prolonged hospital stay (>4 days) and increased total hospital charges. Cakmak et al. [55] evaluated the impact of subcutaneous and visceral abdominal adipose tissue compartments, as assessed by computerized tomography (CT) scan, on PNL success. Only abdominal circumference assessed by CT and stone surface area were independent predictors of PNL success.
Mini-PNL refers to a PNL procedure that is done through shorter and narrower tract size (11-20 Fr). Akbulut et al. [56] studied the outcomes of obesity in 182 patients who underwent mini-PNL. BMI was not associated with any significant difference in mean operation time, mean fluoroscopy time, haemoglobin drop, length of hospital stay, rate of transfusion, or any postoperative complications.
The efficacy and safety of fURS and mini PNL were examined in a retrospective comparative study that included fifty-six obese patients with a 1-2 cm kidney stone in each treatment group [57 & ]. Complication rates were significantly higher in mini-PNL and both interventions achieved acceptable stone-free rates with no statistically significant difference.
In 2016, Ishii et al. [59 && ] published a systematic review that included 15 studies assessing the outcomes of ureteroscopy in obese patients. More than 800 obese patients achieved a mean overall stonefree rate of 82.5%; this decreased to 80.4% in the morbidly obese. The complication rates in morbidly obese patients was twice that of the obese patients. Results from the Clinical Research Office of Endourological Society URS Global Study on more than 10 000 patients showed that ureteroscopy in obese and superobese is well tolerated and effective. However, ureteroscopy was associated with both lower stone-free rates and higher retreatment rates [ 
RENAL TRANSPLANTATION
According to the Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient, obesity is not considered an absolute contraindication to transplantation. However, the guidelines suggested that patients with BMI more than 40 kg/m 2 are less likely to benefit from transplant, and patients with BMI more than 30 kg/m 2 should be screened thoroughly for cardiovascular disease. Consequently, cases should be considered on an individual basis. Indeed, transplantation in this group reflects the technical difficulties of managing obsess patients, and the impact of obesity on renal transplant recipients and graft survival is controversial [62] .
Using the United Network for Organ Sharing, Gore et al. [63] analyzed the effect of obesity in more than 27 000 renal transplant recipients. Morbidly obese patients were independently associated with an increased risk of acute rejection, prolonged hospitalization, delayed graft function (DGF), and decreased graft survival. On the other hand, donor BMI did not affect overall graft survival. Another study demonstrated an independent association between obesity and surgical site infection. No such association was detected between obesity and graft or patient survival. Interestingly, a significant higher risk of premature graft loss and a tendency toward lower patient survival was observed in patients who experienced surgical site infection [64] . Finally, two meta-analyses in 2015 concluded that obesity prior to renal transplantation led to poorer outcomes. [62,65 && ]. Table 2 summarizes selected recent studies about the impact of obesity on renal transplant recipients [66] [67] [68] .
CONCLUSION
Owing to different study designs, heterogeneity of population, BMI cut-offs, reporting of complications, and definition of success, it is difficult to precisely compare all studies and come to definitive conclusions. Further studies are necessary to identify the impact of obesity on perioperative outcomes and to shed light on the unclear aspects. However, the aforementioned studies concluded that nononcological urological procedures in obese patients are feasible and well tolerated. Overall success rates were in line with the reported literature in nonobese patients. However, postoperative outcomes were higher in some studies. Obesity -by its own -should not be regarded as a contraindication for any urological intervention. In fact, it should alert the astute surgeon of a possible challenging procedure and potential risks and complications.
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